Search Results - Andreas Johne

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Cover Image

    Explainable machine learning prediction of edema adverse events in patients treated with tepotinib by Federico Amato, Rainer Strotmann, Roberto Castello, Rolf Bruns, Vishal Ghori, Andreas Johne, Karin Berghoff, Karthik Venkatakrishnan, Nadia Terranova

    Published 2024
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration‐QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy Volunteers by Andreas Becker, Emily C. Martin, David Y. Mitchell, Roland Grenningloh, Andrew T. Bender, Julien Laurent, Harald Mackenzie, Andreas Johne

    Published 2020
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    Translational pharmacokinetic‐pharmacodynamic modeling of preclinical and clinical data of the oral MET inhibitor tepotinib to determine the recommended phase II dose by Wenyuan Xiong, Manja Friese‐Hamim, Andreas Johne, Christopher Stroh, Manfred Klevesath, Gerald S. Falchook, David S. Hong, Pascal Girard, Samer El Bawab

    Published 2021
    Connect to this object online.
    Book

    Save to List
    Saved in:
  4. 4
    Cover Image

    Treatment effectiveness in a rare oncology indication: Lessons from an external control cohort study by Dina Oksen, Patricia Prince, Emmanuelle Boutmy, Elizabeth M. Garry, Barbara Ellers‐Lenz, Adina Estrin, Andreas Johne, Patrice Verpillat, Nicolle M. Gatto

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: